TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
Recruiting
N/A
Interventional Study
Uterine Fibroids (Leiomyoma)
Ovarian Tumors
Gallstones
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 780 (estimated)
- Sponsor
- Zhejiang University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the effects of transcutaneous electrical acupoint stimulation (TEAS) combined with triple antiemetics for postoperative nausea and vomiting (PONV) in high-risk patients.
The primary question it seeks to answer is:
Does TEAS combined with triple antiemetics further reduce the incidence of PONV in high-risk subjects? Researchers will compare active TE…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women scheduled for laparoscopic surgery ；
* Aged 18-65 years；
* ASA Class I-III；
* Apfel score ≥ 3 (female sex, non-smoker, history of PONV and/or motion sickness).
Exclusion Criteria:
* Patients with a history of allergy to the investigational drug or contraindications；
* …
Contacts